Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma

PURPOSE: Glioblastoma (GBM) is the most common primary malignant brain tumor in adults. Despite the best available treatment, prognosis remains poor. Current standard therapy consists of surgical removal of the tumor followed by radiotherapy and chemotherapy with the alkylating agent temozolomide (T...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehinger, Erik, Kopecky, Jan, Darabi, Anna, Visse, Edward, Edvardsson, Charlotte, Tomasevic, Gregor, Cederberg, David, Belting, Mattias, Bengzon, Johan, Siesjö, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938624/
https://www.ncbi.nlm.nih.gov/pubmed/36803465
http://dx.doi.org/10.1186/s12883-023-03119-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938624/
https://www.ncbi.nlm.nih.gov/pubmed/36803465
http://dx.doi.org/10.1186/s12883-023-03119-4

Ejemplares similares